Sarepta Therapeutics (SRPT) EBIT Margin Growth (1y) (2013 - 2026)
Sarepta Therapeutics (SRPT) EBIT Margin Growth (1y) (2013 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
EBIT Margin Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
719,706.53 Bn |
719,706.50 Bn |
- |
- |
| 2 |
Belite Bio |
55,800.00 Bn |
55,800.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
18,182.30 Bn |
18,182.29 Bn |
- |
- |
| 4 |
Legend Biotech |
3,154.00 Bn |
3,153.71 Bn |
242.10 Mn |
3,609.00 |
| 5 |
Akari Therapeutics |
1,844.30 Bn |
1,844.29 Bn |
- |
- |
| 6 |
Evaxion A |
1,567.96 Bn |
1,567.94 Bn |
- |
- |
| 7 |
Psyence Biomedical |
251.43 Bn |
251.42 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
112.56 Bn |
105.31 Bn |
2.59 Bn |
1,536.00 |
| 9 |
Abivax |
94.37 Bn |
94.37 Bn |
- |
- |
| 10 |
Sarepta Therapeutics |
1.63 Bn |
945.44 Mn |
291.52 Mn |
31,483.00 |
| Date | Value |
|---|
| Mar 31, 2026 |
31,483.00 |
| Dec 31, 2025 |
-11,748.00 |
| Sep 30, 2025 |
-3,064.00 |
| Jun 30, 2025 |
1,911.00 |
| Mar 31, 2025 |
-23,373.00 |
| Dec 31, 2024 |
1,924.00 |
| Sep 30, 2024 |
1,103.00 |
| Jun 30, 2024 |
59,989.00 |
| Mar 31, 2024 |
6,291.00 |
| Dec 31, 2023 |
6,846.00 |
| Sep 30, 2023 |
5,694.00 |
| Jun 30, 2023 |
-50,012.00 |
| Mar 31, 2023 |
34,035.00 |
| Dec 31, 2022 |
3,135.00 |
| Sep 30, 2022 |
-4,503.00 |
| Jun 30, 2022 |
1,818.00 |
| Mar 31, 2022 |
-29,147.00 |
| Dec 31, 2021 |
66,444.00 |
| Sep 30, 2021 |
59,113.00 |
| Jun 30, 2021 |
41,359.00 |
